The Cass review, conducted by Hilary Cass in April 2024, highlighted issues with NHS services for children and young people questioning their gender identity. The review pointed out lack of evidence on long-term effects of hormonal prescriptions for young people with gender dysphoria, leading to a call for more evidence-based and holistic services. The toxic debate around the issue has hindered discussions and potential whistleblowing within the medical field. The comparison to past mistakes in treating homosexuality as an illness urges medical institutions to reexamine their approach. Strong leadership, rational debate, and acknowledgment of uncertainty are recommended for avoiding similar mistakes in the future.
Source link
Medical institutions must treat the Cass review as a significant event and act upon it
